Fibronostics
PrivateLast Round
Series A
Extension
Jun 15, 2022
Total Funding Raised
$14.5M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Fibronostics is a healthcare technology company that provides non-invasive, AI-driven diagnostic solutions for chronic, metabolic, and liver diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Healthcare Analytics, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Fibronostics Comparables
Compare Fibronostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BioPredictive | 85% | |
| MetaDeq | 82% | |
| Oncoustics | 78% |
Fibronostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jun 15, 2022 | ||||
| Series A | Aug 24, 2020 | ||||
| Seed | May 31, 2019 |
Fibronostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Tikehau Capital | Series A |
| AT Capital Group | Series A |
| SPRIM Global Investments | Seed, Series A |
| Elev8.vc | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 16, 2026
Monthly visitors increased 34% MoM.
- Jun 1, 2025
Monthly visitors grew 33% MoM.
Fibronostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Fibronostics's valuation, stock price, and market status.
Is Fibronostics a public or private company?
Fibronostics is a private company.
What is the current stock price of Fibronostics?
Fibronostics is a private company with no public stock price. No recent secondary market data is available.
How much is Fibronostics worth (valuation)?
Valuation information for Fibronostics is not publicly available.
Can I buy Fibronostics stock?
Fibronostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Fibronostics's last funding round?
Fibronostics's most recent funding round was Series A Extension on June 15, 2022.
Who are the main investors in Fibronostics?
Key investors in Fibronostics include AT Capital Group, Elev8.vc.
Will Fibronostics IPO soon?
No public IPO plans have been announced for Fibronostics.
How can I track Fibronostics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Fibronostics's secondary market activity and sign up for updates.